Clinical Trials Logo

Clinical Trial Summary

The rapid progress of multiple antiemetic regimens ensures that patients can receive full dose chemotherapy, however, there are still a large number of unmet clinical needs in patient evaluation and treatment. Due to the fact that patients with liver, gallbladder, and pancreatic diseases undergoing surgery are still in the stage of nausea and vomiting, the actual incidence of delayed nausea and vomiting may be underestimated. The long-term effective control of nausea and vomiting by Nitopitan Palonosetron capsules may improve the quality of life of patients during and after treatment, and ultimately improve clinical outcomes


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06417567
Study type Observational [Patient Registry]
Source Tianjin Medical University Cancer Institute and Hospital
Contact
Status Recruiting
Phase
Start date May 15, 2024
Completion date December 31, 2026